patients evaluable

Related by string. * PATIENTS . PATIENT . Patients . pa tients . pa tient . Patient : Breast Cancer Patients . terminally ill patients . Patient Safety . Improving Patient Outcomes . chronically ill patients . Patient Centered Medical / Evaluable : evaluable patients . evaluable subjects . clinically evaluable population . microbiologically evaluable . clinically evaluable patients * *

Related by context. Frequent words. (Click for all words.) 83 evaluable patients 81 evaluable 73 RECIST criteria 68 RECIST 66 dose cohorts 66 tumor shrinkage 66 Secondary endpoints 65 mg BID 65 FOLFOX 65 free survival PFS 65 tumor regression 64 Secondary endpoints include 64 chemoradiation 64 Secondary endpoints included 64 mcg kg 63 adalimumab 63 dasatinib 63 events SAEs 63 peginterferon 63 plus methotrexate 63 FOLFIRI 63 TELCYTA 63 imatinib 63 dose limiting toxicities 63 GVAX 63 gefitinib 62 azacitidine 62 median PFS 62 decitabine 62 ACTEMRA 62 Median survival 62 febrile neutropenia 62 rituximab 62 STELARA 62 peginterferon alfa 2a 62 infliximab 62 vandetanib 62 TORISEL 61 etanercept 61 composite endpoint 61 hematologic 61 Taxotere ® 61 liver metastases 61 discontinuations due 61 sustained virologic response 61 HGS ETR1 60 metastatic renal cell carcinoma 60 nilotinib 60 mg dose 60 IMGN# 60 interferon alfa 60 temsirolimus 60 HCV infected 60 peginterferon alfa 2b 60 dose escalation 60 events AEs 60 hypercalcemia 59 seroconversion 59 distant metastases 59 tumor recurrence 59 n = 59 bortezomib 59 monotherapy 59 laboratory abnormalities 59 patients receiving ERBITUX 59 entecavir 59 fluorouracil 59 treatment emergent adverse 59 SUTENT 59 azathioprine 58 bosentan 58 abatacept 58 topotecan 58 mitoxantrone 58 anakinra 58 discontinuations 58 sunitinib 58 plus ribavirin 58 nonresponders 58 mg/m2 58 Phase 1b 58 microgram dose 58 secondary endpoint 58 allogeneic stem cell 58 vinorelbine 58 ketoconazole 58 vicriviroc 58 prespecified 58 zoledronic acid 58 rotigotine 58 raltegravir 58 secondary endpoints 58 COPAXONE R 58 vertebral fracture 58 dose regimens 57 NSCLC 57 Tolerability 57 adefovir 57 fludarabine 57 randomized #:# 57 docetaxel

Back to home page